The COVID-19 vaccine from Moderna has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
Package leaflet: Information for the user
Spikevax 0.1 mg/mL dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)
Following vaccination, you should be alert to signs of myocarditis and pericarditis, such as breathlessness, palpitations and chest pain, and seek immediate medical attention should these occur.
h/t A Deplorable Neanderthal
Views: